Meanwhile, inhibition of VEGFC expression and blocking the VEGFC/VEGFR3 signaling pathway both rescued the effect of CRIP1 in inducing lymphangiogenesis and LM in GC. This evidence concerns the gene FLT4 and gastric cancer.